Alzheimer's Drug Discovery Foundation
@TheADDF
Followers
19K
Following
3K
Media
2K
Statuses
6K
The Alzheimer's Drug Discovery Foundation's mission is to rapidly accelerate the discovery and development of drugs to prevent, treat, and cure #Alzheimers.
New York, NY
Joined February 2009
We are deeply saddened to share the passing of ADDF Co-Founder Leonard A. Lauder. Alongside his brother, Leonard founded the ADDF in 1998, transforming the Alzheimer's research landscape through their vision, catalytic funding, venture philanthropy.
1
7
22
Karen Harris chats with @PharmaVoice about the evolving biotech landscape, the recent challenges and latest developments. “There’s so much opportunity right now, I see a lot of promise ahead for therapies based on the biology of aging.” #BIO2025 .
0
0
0
Today, the FDA approved an updated label for Kisunla for early-stage Alzheimer’s, with a new dosing schedule to lower ARIA risk, marking a critical step in clinical care and moving us closer to combination therapy and precision medicine. @EliLillyandCo .
0
4
9
Exciting news from our funded investigators @CircGenomics! Our investment is advancing circRNA, a novel blood-based biomarker for diagnosing and predicting Alzheimer's progression, supported by Diagnostics Accelerators (DxA).
Circular Genomics has been awarded a $250K investment from the Alzheimer’s Drug Discovery Foundation to advance our circular RNA blood-based early detection diagnostic testing for Alzheimer’s Disease. Read the full press release here:
0
0
0
Dr. Fillit, discusses how the new Lumipulse blood test—developed by Fujirebio and funded by the Diagnostics Accelerators (DxA)— is revolutionizing Alzheimer’s diagnostics. For the first time, tools are affordable, accessible, and scalable. @NeurologyToday.
0
0
2
Tune in to the latest episode of @Biotech2050Pod as @TheADDFCEO and @a_hfillit share how the ADDF is pioneering early detection, bold funding strategies, and the future of treatment.
🎙️#Biotech2050 host @aloktayi chats with @a_hfillit & @TheADDFCEO of @TheADDF on how they’re reshaping Alzheimer’s R&D—from blood tests to biotech bets. Discover how mission meets innovation. 🎧 Listen now: #Alzheimers #DrugDiscovery #HealthcareFunding
0
1
3
Alzheimer’s is at a pivotal moment, and so is the science behind it. In a new interview with @WuXi_AppTec, Dr. Howard Fillit shares how we're entering a new era in Alzheimer's research, driven by early detection, innovative science and bold funding models.
0
0
2
From combination therapies to cutting-edge blood tests, Karen Harris highlights the ADDF’s pivotal role in the Alzheimer’s ecosystem, sharing key insights into where the field is headed and how the ADDF is leading the science to bring us what comes next.
0
0
0
In @statnews, @BillGates highlights progress in early detection & Alzheimer’s treatment. The FDA approval of the first blood test, supported by ADDF’s DxA, represents a transformative advance for clinical trials, therapies, and patient hope.
0
3
4
A new study published in @journal_ad links Ozempic to a lower Alzheimer’s risk in type 2 diabetes. Building on Dr. Edison’s ADDF-funded liraglutide trial, these findings highlight the growing connection between metabolic and brain health. @Newsweek .
0
0
1
The FDA approved an updated label for Amyvid, a brain imaging diagnostic that detects amyloid. Developed by Goodes Prize Winner Dan Skovronsky & supported by ADDF, this will help physicians detect amyloid buildup earlier and guide treatment. @EliLillyandCo.
0
0
2
@ADDFCEO & Dr. Fillit of ADDF joined @aloktayi on @Biotech2050Pod for a powerful convo on the future of Alzheimer’s innovation:.– ADDF’s venture philanthropy model.– Urgency of risk-taking in drug development .– Innovation amid federal funding pressure.
0
1
2
RT @TheADDFCEO: ⸻. I waited to post, honoring Leonard Lauder’s passing. Then Bill Gates shared this note on Alzheimer’s and the ADDF:.🔗 ht….
0
1
0
RT @UAZCIBS: Dr. Brinton is excited to be part of today's panel @AspenIdeas, sharing her insights on the center's research advances in Alzh….
0
1
0
The latest Gates Notes highlights the promise of blood-based diagnostics, marking a transformative era in Alzheimer’s care. @BillGates' recognition of the DxA affirms ADDF’s leadership and vision, turning high-risk investments into high-reward outcomes.
0
0
2
RT @EricTopol: "But I am blown away by how much we have learned about Alzheimer’s over the last couple of years."—@BillGates . https://t.co/….
0
110
0
The USC Clinical Trial Recruitment Lab calls for more inclusive, equitable access to Alzheimer’s clinical trials in a new @journal_ad paper—featuring insights from leaders across the field, including ADDF Board Members @niranjanbose and @PhylFerrell.
0
3
5
On the latest episode of @ThePharmaLetter, Dr. Howard Fillit joins host Simon Wentworth to discuss what’s next for Alzheimer’s and how the ADDF is shaping the next generation of Alzheimer’s through combination therapy, precision medicine and prevention.
0
0
0
RT @MGBResearchNews: In a new study, researchers from @WrannLab at @MassGeneralNews and colleagues discovered how exercise can protect the….
0
7
0
A new study from @MassGenBrigham, published in Nature, shows how exercise influences brain health. The study supports a core tenet of the ADDF that, with lifestyle interventions & therapeutic discovery, combination therapy is possible. @WrannLab.
0
0
0